Provided by Tiger Fintech (Singapore) Pte. Ltd.

Post-Pandemic Stocks

1,555.691
-2.197-0.14%
Number of Gainers:6
Number of Losers:11
Number of Flat:1
PE:- -
High:1,591.307
Open:1,557.606
Low:1,549.144
Close:1,557.889
Volume:431.67M
Turnover:4.98B
Market Cap:1.03T
Float Cap:873.07B

Loading ...

Hong Kong Stock Market Analysis | Short Selling in the Invisible Battlefield as Energy Storage Sector Surges

Stock News
·
Sep 04

Excellent New Energy Light Truck for RV Conversion: BYD's 10,000th T5 Production Vehicle Rolls Off Assembly Line

Deep News
·
Sep 04

Sino Biopharmaceutical Stock Sheds 2.8% in Hong Kong

Dow Jones
·
Sep 04

Venture Capital Monthly Report | JYM Investment: Six Funds Raised Over 2.6 Billion Yuan in Eight Months, Growth-Stage Project Investments Account for Over 80%

Deep News
·
Sep 04

Deluxe Family Re-enters Pharmaceutical Sector as Foreign Capital Rushes In While Private Equity Giant Exits

Deep News
·
Sep 03

FTSE China A50 Index Quarterly Review: Adds BeiGene (688235.SH), Wuxi Apptec Co.,Ltd. (603259.SH), Removes China National Nuclear Power Co.,Ltd. (601985.SH) and Others

Stock News
·
Sep 03

Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH): Ceftazidime for Injection Passes Generic Drug Consistency Evaluation

Stock News
·
Sep 03

Alibaba Health Information Technology Stock Advances 4.6% in Hong Kong

Dow Jones
·
Sep 03

AH Stock Premium Statistics | September 3rd

Stock News
·
Sep 03

Automotive Companies Show Divergent H1 Performance: BYD Company Limited Earns 15.5 Billion Yuan While GAC Group Turns to Loss

Deep News
·
Sep 03

Shanghai Junshi Biosciences' Monkey Pox Vaccine Approved for Human Trials

MT Newswires Live
·
Sep 03

BUZZ-Sihuan Pharma hits 3-1/2-year peak on share buyback, growth optimism

Reuters
·
Sep 03

CICC Maintains Outperform Rating on BYD Electronic, Raises Target Price to HK$50

Deep News
·
Sep 03

Hong Kong Stock Market Preview | Spot Gold Reaches $3,530, Southbound Capital's Annual Net Purchases Hit Record High

Stock News
·
Sep 03

Shanghai Junshi Biosciences - Jt118 Injection Received Notice of Approval for Clinical Trial From Nmpa

THOMSON REUTERS
·
Sep 02

Shanghai Junshi Biosciences (688180.SH) Plans to Grant 26.18 Million Stock Options at Exercise Price of 46.67 Yuan Per Share

Stock News
·
Sep 02

Shanghai Junshi Biosciences Co.,Ltd. (688180.SH): JT118 Injection Clinical Trial for Monkeypox Virus Prevention Receives Approval

Stock News
·
Sep 02

Ascletis Pharma to Present Obesity Drug Study Data at Annual Diabetes Conference

MT Newswires Live
·
Sep 02

August New Energy Vehicle Wholesale Sales Rankings Released: BYD Leads, Geely and Tesla Follow

Deep News
·
Sep 02

ASCLETIS-B (01672) to Present ASC30 Oral Small Molecule GLP-1R Agonist 28-Day Multiple Ascending Dose Study Results at 61st EASD Annual Meeting

Stock News
·
Sep 02